Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold 5,771 shares of common stock on April 1, 2025, to cover tax withholding obligations related to vesting restricted stock.
Summary
- On April 1, 2025, Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc., sold 5,771 shares of the company's common stock.
- The sale was executed at a price of $22.66 per share.
- Following the transaction, Aebersold directly owns 80,094 shares of BioLife Solutions Inc.
- The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023, to cover tax obligations associated with the vesting of restricted stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and was pre-planned.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1(c) trading plan, indicating it was planned and not based on immediate market conditions.
Industry Context
Insider transactions are routinely monitored and reported to the SEC. Sales to cover tax obligations on vesting equity are common.
Stakeholder Impact
- The sale may have a minor impact on shareholders due to the small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Date of adoption of Rule 10b5-1(c) trading plan |
| 04/01/2025 | Date of stock sale transaction |
| 04/03/2025 | Date of Form 4 filing |
Keywords
BioLife Solutions, BLFS, Sarah Aebersold, insider trading, Form 4, stock sale, Rule 10b5-1, tax obligations, restricted stock, Chief Human Resources Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.